Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma
Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma
复制标题
DOI:
10.1007/s004280050319
复制
发表时间:
1999-02-01
期刊:
影响因子:
3.5
通讯作者:
Ogoshi, S
中科院分区:
文献类型:
--
作者:
Murakami, H;Furihata, M;Ogoshi, S
Recent studies have identified a family of proteins referred to as cyclins, which control the cell cycle. Cyclin B1 activates cdc2, which regulates cell progression through the G2 and M phases. The main aim of this study was to examine the relationships between the cyclin B1 expression in human esophageal squamous cell carcinoma (SCC) and clinicopathological factors and prognosis of the patients. Eighty-seven cases of primary human SCC consecutively obtained at esophagectomy were immunohistochemically studied using an anti-human cyclin B1 protein antibody (2H1-H6). The relationship between cyclin B1 expression and clinicopathological factors, including prognosis, were also statistically assessed. Positive immunostaining of cancer cells, mainly in the cytoplasm, was detected in 72.4% (63/87): heterogeneous pattern in 37.9% (33/87) and homogeneous pattern in 34.5% (30/87). The prevalence of cyclin B1 expression was significantly higher in cases with invasion deeper than the muscularis propria (P